000			02256cam a2200253 a 4500
020			_a9780521195768 (hardback)
020			_a0521195764 (hardback)
082	0	0	_a344.04/194
100	1		_aFovargue, Sara,
245	1	0	_aXenotransplantation and risk : _bregulating a developing biotechnology / _cSara Fovargue
264			_bCAMBRIDGE UNIVERSITY PRESS _c2012
300			_axiii, 291 p. ;
490	1		_aCambridge law, medicine and ethics
505	8		_aMachine generated contents note: 1. Introducing the issues; 2. Dealing with risk; 3. Regulating experimental procedures and medical research; 4. Regulatory responses to developing biotechnologies; 5. Challenges to legal and ethical norms: first party consent and third parties at risk; 6. Surveillance and monitoring: balancing public health and individual freedom; 7. Looking to the future
520			_a"Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"--
650		0	_aXenografts
650		0	_aTransplantation immunology
650		0	_aXenografts
650		0	_aTransplantation of organs, tissues, etc
650		2	_aTransplantation, Heterologous
650		2	_aTransplantation, Heterologous
650		2	_aTransplantation, Heterologous
942			_2lcc _cBK
999			_c12680 _d12680